Share This Article:

Diphenyl methane laxatives do not induce electrolyte imbalance

Abstract Full-Text HTML Download Download as PDF (Size:106KB) PP. 272-275
DOI: 10.4236/ojgas.2013.35046    4,539 Downloads   6,175 Views  

ABSTRACT

Aim: To analyse whether there are changes in sodium and potassium serum levels during chronic treatment with the diphenyl methanes bisacodyl and sodium picosulfate. Methods: A literature search was done using PubMed, and the reference lists of pertinent papers were screened for additional studies. Only studies of at least 4 weeks duration were considered for further analysis. Results: Four relevant studies were identified. In three randomised controlled trials with 5 to 10 mg daily of bisacodyl or sodium picosulfate, respectively, over four weeks no electrolyte losses were found. Hypokalemia was also not a problem in a group of patients with paraplegia using bisacodyl suppositories for 2 to 34 years. Conclusions: Electrolyte losses, particularly hypokalemia, are not a problem when bisacodyl or sodium picosulfate are used long-term.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Müller-Lissner, S. (2013) Diphenyl methane laxatives do not induce electrolyte imbalance. Open Journal of Gastroenterology, 3, 272-275. doi: 10.4236/ojgas.2013.35046.

References

[1] Binder, H.J. and Donowitz, M. (1975) A new look at laxative action. Gastroenterology, 69, 1001-1005.
[2] Hervé, S., Savoye, G., Behbahani, A., Leroi, A.M., Denis, P. and Ducrotté, P. (2004) Results of 24-h manometric recording of colonic motor activity with endoluminal instillation of bisacodyl in patients with severe chronic slow transit constipation. Neurogastroenterology and Motility, 16, 397-402. doi:10.1111/j.1365-2982.2004.00535.x
[3] Bundesvereinigung Deutscher Apothekerverbande, 2011. http://www.abda.de/
52+B6JmNIYXNoPTMyMjllYmNhMTQmdHhfdHRuZXdzW2JhY2tQaWRd
PTI0JnR4X3R0bmV3c1twb2ludGVyXT01JnR4X3R0bmV3c1t0dF9uZXdzXT0xMzU4.html
[4] ADRAC (2002) Electrolyte disturbances with sodium picosulfate bowel cleansing products. Australian Adverse Drug Reactions Bulletin, 21, 1-4.
[5] (1997) Consumer reports complete drug reference, 981-988.
[6] Fruit-Eze, Inc. Laxative Warnings, Side Effects & Contraindications Reported in Medical Literature.
http://web.pdx.edu/~sujata/FruitEze/education/laxative/medical_warnings.html#1
[7] Bytzer, P., Stokholm, M., Andersen, I., Klitgaard, N.A. and Schaffalitzky de Muckadell, O.B. (1989) Prevalence of surreptitious laxative abuse in patients with diarrhoea of uncertain origin: A cost benefit analysis of a screening procedure. Gut, 30, 1379-1384. doi:10.1136/gut.30.10.1379
[8] Cummings, J.H., Sladen, G.E., James, O.F.W., Sarner, M. and Misiewicz, J.J. (1974) Laxative-induced diarrhoea: A continuing clinical problem. British Medical Journal, 1, 537. doi:10.1136/bmj.1.5907.537
[9] Read, N.W., Krejs, G.J. and Read, M.G. (1980) Chronic diarrhea of unknown origin. Gastroenterology, 78, 264-271.
[10] Ruidisch, M.H., Hutt, H.-J. and Konig, E. (1994) Laxanzien-langzeittherapie mit bisacodyl. Wirksamkeit und vertraglichkeit bei patienten mit rückenmarkverletzungen. Arztliche Forschung, 41, 3-8.
[11] Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C. (2006) Functional bowel disorders. Gastroenterology, 130, 1480-1491. doi:10.1053/j.gastro.2005.11.061
[12] Thompson, W.G., Longstreth, G.F., Drossman, D.A., Heaton, K.W., Irvine, E.J. and Müller-Lissner, S.A. (1999) Functional bowel disorders and functional abdominal pain. Gut, 45, II43-II47. doi:10.1136/gut.45.2008.ii43
[13] Kienzle-Horn, S., Vix, J.M., Schuijt, C., Peil, H., Jordan, C.C. and Kamm, M.A. (2007) Comparison of bisacodyl and sodium picosulfate in the treatment of chronic constipation. Current Medical Research and Opinion, 23, 891-899. doi:10.1185/030079907X178865
[14] Kamm, M.A., Mueller-Lissner, S., Wald, A., Richter, E., Swallow, R. and Gessner, U. (2011) Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clinical Gastroenterology and Hepatology, 9, 577-583. doi:10.1016/j.cgh.2011.03.026
[15] Müller-Lissner, S.A., Kamm, M.A., Scarpignato, C. and Wald, A. (2005) Myths and misconceptions about chronic constipation. American Journal of Gastroenterology, 100, 232-242. doi:10.1111/j.1572-0241.2005.40885.x
[16] Müller-Lissner, S.A. (1996) What has happened to the cathartic colon? Gut, 39, 486-488. doi:10.1136/gut.39.3.486
[17] Kienzle-Horn, S., Vix, J.M., Schuijt, C., Peil, H., Jordan, C.C. and Kamm, M.A. (2006) Efficacy and safety of bisacodyl in the acute treatment of constipation: A doubleblind, randomized, placebo-controlled study. Alimentary Pharmacology & Therapeutics, 23, 1479-1488. doi:10.1111/j.1365-2036.2006.02903.x
[18] Hinkel, U., Schuijt, C. and Erckenbrecht, J. (2008) OTC laxative use of sodium picosulfate—Results of a pharmacy-based patient survey (cohort study). International Journal of Clinical Pharmacology and Therapeutics, 46, 89-95.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.